124 related articles for article (PubMed ID: 7412949)
1. [Chemotherapy of stage III and IV ovarian carcinoma].
Neijt JP; Barents JW; Vendrik CP; van Lindert AC; Struyvenberg A; Pinedo HM
Ned Tijdschr Geneeskd; 1980 Sep; 124(38):1601-5. PubMed ID: 7412949
[No Abstract] [Full Text] [Related]
2. [Progress in the chemotherapy of ovarian cancer].
Honetz N
Wien Med Wochenschr; 1982 Jul; 132(13-14):319-24. PubMed ID: 6291259
[No Abstract] [Full Text] [Related]
3. [High dose chemotherapy in ovarian and breast adenocarcinoma with poor prognosis].
Lotz JP; Gligorov J; Selle F; Lefevre G; Pautier P; Lhommé C
Gynecol Obstet Fertil; 2000 Sep; 28(9):620-31. PubMed ID: 11075500
[No Abstract] [Full Text] [Related]
4. [Comparative study of 2 combined chemotherapy protocols in the treatment of stage III-IV ovarian cancer patients].
Marenich AF; Perevodchikova NI; Grigorova TM; Pashkiavichus RI
Vestn Akad Med Nauk SSSR; 1980; (5):28-32. PubMed ID: 7395336
[No Abstract] [Full Text] [Related]
5. [Comparison of the effectiveness of poly- and monochemotherapy in the combination therapy of malignant ovarian tumors].
Khasanova DT; Nechaeva ID
Vopr Onkol; 1981; 27(3):85-97. PubMed ID: 7013262
[No Abstract] [Full Text] [Related]
6. [Role of chemotherapy in the ovarian malignancy treated with reduction surgery (author's transl)].
Terashima Y; Yasuda M; Tajima T; Ota Y; Okawa K
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Sep; 33(9):1355-70. PubMed ID: 7276656
[No Abstract] [Full Text] [Related]
7. [Chemotherapy of ovarian cancers, stage III].
Amiel JL
Nouv Presse Med; 1978 Oct; 7(35):3150-1. PubMed ID: 724482
[No Abstract] [Full Text] [Related]
8. Use of the collagen gel droplet embedded drug sensitivity test to determine drug sensitivity against ovarian mature cystic teratoma with malignant transformation to adenocarcinoma: a case report.
Yamagami W; Banno K; Kawaguchi M; Yanokura M; Kuwabara Y; Hirao N; Susumu N; Tsukazaki K; Aoki D
Chemotherapy; 2007; 53(2):137-41. PubMed ID: 17308380
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
10. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
[TBL] [Abstract][Full Text] [Related]
11. Glutathione, glutathione S-transferase alpha and pi, and aldehyde dehydrogenase content in relationship to drug resistance in ovarian cancer.
Tanner B; Hengstler JG; Dietrich B; Henrich M; Steinberg P; Weikel W; Meinert R; Kaina B; Oesch F; Knapstein PG
Gynecol Oncol; 1997 Apr; 65(1):54-62. PubMed ID: 9103391
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for ovarian cancer.
Adlan A; Sen DK; Sivanesaratnam V
Med J Malaysia; 1981 Sep; 36(3):159-65. PubMed ID: 7329372
[No Abstract] [Full Text] [Related]
13. [New developments in the chemotherapy of ovarian cancer (author's transl)].
Brunner KW; Goldhirsch A; Joss R
Schweiz Rundsch Med Prax; 1981 Apr; 70(18):809-14. PubMed ID: 7243721
[No Abstract] [Full Text] [Related]
14. [Chemotherapy for ovarian cancer].
Lindell A
Lakartidningen; 1968 Mar; 65(11):1120-2. PubMed ID: 5743130
[No Abstract] [Full Text] [Related]
15. [Simultaneous radio-chemotherapy in advanced ovarian carcinoma--phase I].
Szepesi T; Seitz W; Kogelnik HD; Reinartz G; Kärcher KH
Strahlentherapie Sonderb; 1978; 75():180-4. PubMed ID: 400198
[No Abstract] [Full Text] [Related]
16. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].
Zhao XD; Zhang Q; Zhang Y
Ai Zheng; 2005 Aug; 24(8):1002-5. PubMed ID: 16086882
[TBL] [Abstract][Full Text] [Related]
17. [Adjuvant chemotherapy in patients operated on for early ovarian carcinoma].
Trimbos JB; van der Burg ME
Ned Tijdschr Geneeskd; 2004 May; 148(18):874-8. PubMed ID: 15152388
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide, cisplatin, and leuprolide acetate in patients with debulked stage III or IV ovarian carcinoma.
Erickson LD; Hartmann LC; Su JQ; Nielsen SN; Pfeifel DM; Goldberg RM; Levitt R; Stanhope CR
Gynecol Oncol; 1994 Aug; 54(2):196-200. PubMed ID: 8063245
[TBL] [Abstract][Full Text] [Related]
19. [Survival in ovarian cancer treated in a gynecological department of a central hospital].
Dragsted NO; Nørgaard M; Bøsling KB
Ugeskr Laeger; 1997 May; 159(20):3003-9. PubMed ID: 9190729
[TBL] [Abstract][Full Text] [Related]
20. New options for the treatment of advanced ovarian cancer.
Dunton CJ
Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
